Table 2.
Summary of demographic and clinical details of residents living at Chalfont Centre for Epilepsy (CCE).
| All (n = 98) |
SARS-CoV-2 positive (n = 10) | SARS-CoV-2 negative (n = 88) | |
|---|---|---|---|
| Male gender n, % | 66 (67%) | 9 (90%) | 57 (65%) |
| Age in years, mean (range) | 49 (23–91) | 49 (33–69) | 48 (23–91) |
| BAME | 5 (5%) | 2 (20%) | 3 (3%) |
| Fever (>37.8) and/or respiratory symptoms n, % | 10 (10%) | 2 (20%) | 8 (9%) |
| Asymptomatic | 88 (90%) | 8 (80%) | 80 (91%) |
| Clinical frailty scale (1–9) mean (range) | 5.88 (3–8) |
5.3 (3–8) |
5.9 (3–8) |
| Cardiac co-morbidity | 15 (15%) | 1 (10%) | 14 (16%) |
| Chronic respiratory disease | 21 (21%) | 2 (20%) | 19 (22%) |
| Immunosuppression | 6 (6%) | 0 | 6 (7%) |
| Death | 1 (1%) | 1 | 0 |
BAME – Black, Asian and Minority Ethnic.